Sanmina Corp. Hits New 52-Week High of USD 270.30, Soars 296.79%

Sanmina Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting a new 52-week high of USD 270.30 on May 28, 2026. This achievement underscores the company's remarkable performance over the past year, with a staggering 296.79% increase compared to the S&P 500's 28.45% gain during the same period. The company's financial metrics reflect strong operational efficiency, highlighted by a return on equity (ROE) of 12.64% and a net-debt-free status. Sanmina Corp. has also reported impressive growth in net profit, soaring by 90.01% as of March 26, with operating cash flow reaching its highest at USD 977.35 million and net sales hitting USD 4,013.27 million. Additionally, the stock's price-to-book ratio stands at 4.95, indicating a fair valuation relative to its peers. Promoter confidence is also on the rise, with a 2.11% increase in stake over the previous quarter, reflecting a positive outlook on the company's future. Overall, Sanmina Corp.'s recent performance and financial health position it favorably within the market.